vTv Therapeutics
VTVT
VTVT
17 hedge funds and large institutions have $1.37M invested in vTv Therapeutics in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
-2
Holders Change %
-10.53%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
D.E. Shaw & Co
New York
|
+$186K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$106K |
| 3 |
Barclays
London,
United Kingdom
|
+$58.1K |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
+$2K |
| 5 |
AG
Advisor Group
Phoenix,
Arizona
|
+$2K |
Top Sellers
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$42.4K |
| 2 |
ARTA
A.R.T. Advisors
New York
|
-$19K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$13K |
| 4 |
Goldman Sachs
New York
|
-$12K |
| 5 |
Millennium Management
New York
|
-$11.8K |
